Fibrotic diseases are characterized by the replacement of healthy tissue with scar tissue and extracellular matrix in response to tissue damage. Here we describe the reduction of extracellular matrix (ECM) deposition interstitial fibroblasts interstitial volume expression of Collagen I mRNA and protein expression of profibrotic cytokines and macrophage infiltration by Cysteamine treatment.